Comparing the post-operative complications following surgery for hip fracture of patients who were on warfarin versus patients who were on novel oral anticoagulants: a meta-analysis

Table 3 Baseline features of the participants

Studies	Age (years)	Males (%)	HBP (%)	DM (%)	HF surgery within 24 h (%)	HF surgery after 24 h (%)
Studies	W/NOAC	W/NOAC	W/NOAC	W/NOAC	W/NOAC	W/NOAC
Aigner 2022	85.0/85.0	28.1/28.1	-	-	-	-
Bruckbauer 2019	83.0/87.0	45.8/35.2	-	-	50.8/37.0	8.50/13.0
Cafaro 2019	90.0/86.0	46.4/22.6	-	-	-	-
Creeper 2022	83.0/83.0	28.7/28.7	-	-	53.0/53.0	87.7/87.7
Daugaard 2019	-	38.2/37.6	-	-	41.6/49.2	29.1/25.4
Elete 2023	85.0/86.0	29.0/29.0	-	-	-	-
Lott 2018	83.8/83.8	-	-	-	-	-
Mahmood 2021	83.8/84.3	46.0/30.0	-	-	-	-
Noll 2023	81.4/83.2	27.5/29.0	48.9/59.5	17.1/19.8	72.6/37.8	27.4/62.2
Rostagno 2023	87.3/86.7	25.0/24.6	-	-	-	-
Rutenberg 2018	82.2/82.9	30.7/35.6	-	-	-	-
Saliba 2020	81.4/83.4	40.5/35.2	93.9/91.9	39.9/42.1	-	-
Tran 2015	86.0/86.0	37.0/37.0	-	-	-	-

Abbreviations: HBP hypertension, DM diabetes mellitus, CVD cardiovascular diseases, W warfarin, NOACs novel oral anticoagulants, HF hip fracture

ISSN: 2047-0525